These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16289818)

  • 1. Guiding farnesyltransferase inhibitors from an ECLiPS library to the catalytic zinc.
    Huang CY; Stauffer TM; Strickland CL; Reader JC; Huang H; Li G; Cooper AB; Doll RJ; Ganguly AK; Baldwin JJ; Rokosz LL
    Bioorg Med Chem Lett; 2006 Feb; 16(3):507-11. PubMed ID: 16289818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferase.
    Nara S; Tanaka R; Eishima J; Hara M; Takahashi Y; Otaki S; Foglesong RJ; Hughes PF; Turkington S; Kanda Y
    J Med Chem; 2003 Jun; 46(12):2467-73. PubMed ID: 12773050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design of imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase.
    Ohkanda J; Strickland CL; Blaskovich MA; Carrico D; Lockman JW; Vogt A; Bucher CJ; Sun J; Qian Y; Knowles D; Pusateri EE; Sebti SM; Hamilton AD
    Org Biomol Chem; 2006 Feb; 4(3):482-92. PubMed ID: 16446806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid-phase synthesis and pharmacological evaluation of a library of peptidomimetics as potential farnesyltransferase inhibitors: an approach to new lead compounds.
    Gilleron P; Millet R; Houssin R; Wlodarczyk N; Farce A; Lemoine A; Goossens JF; Chavatte P; Pommery N; Hénichart JP
    Eur J Med Chem; 2006 Jun; 41(6):745-55. PubMed ID: 16647166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme flexibility and the catalytic mechanism of farnesyltransferase: targeting the relation.
    Sousa SF; Fernandes PA; Ramos MJ
    J Phys Chem B; 2008 Jul; 112(29):8681-91. PubMed ID: 18572907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and activity of achiral analogs of 2-quinolones and indoles as non-thiol farnesyltransferase inhibitors.
    Li Q; Woods KW; Wang W; Lin NH; Claiborne A; Gu WZ; Cohen J; Stoll VS; Hutchins C; Frost D; Rosenberg SH; Sham HL
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2033-9. PubMed ID: 15808463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfing the piperazine core of tricyclic farnesyltransferase inhibitors.
    Rokosz LL; Huang CY; Reader JC; Stauffer TM; Chelsky D; Sigal NH; Ganguly AK; Baldwin JJ
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5537-43. PubMed ID: 16202593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent and selective farnesyl transferase inhibitors.
    Millet R; Domarkas J; Houssin R; Gilleron P; Goossens JF; Chavatte P; Logé C; Pommery N; Pommery J; Hénichart JP
    J Med Chem; 2004 Dec; 47(27):6812-20. PubMed ID: 15615530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors.
    Dublanchet AC; Ducrot P; Andrianjara C; O'Gara M; Morales R; Compère D; Denis A; Blais S; Cluzeau P; Courté K; Hamon J; Moreau F; Prunet ML; Tertre A
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3787-90. PubMed ID: 16002291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential.
    Tanaka R; Rubio A; Harn NK; Gernert D; Grese TA; Eishima J; Hara M; Yoda N; Ohashi R; Kuwabara T; Soga S; Akinaga S; Nara S; Kanda Y
    Bioorg Med Chem; 2007 Feb; 15(3):1363-82. PubMed ID: 17127066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of imidazole-containing analogues of farnesyl pyrophosphate and evaluation of their biological activity on protein farnesyltransferase.
    Coudray L; de Figueiredo RM; Duez S; Cortial S; Dubois J
    J Enzyme Inhib Med Chem; 2009 Aug; 24(4):972-85. PubMed ID: 19555171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
    Mitsch A; Bergemann S; Gust R; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):242-50. PubMed ID: 12916059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors.
    Asoh K; Kohchi M; Hyoudoh I; Ohtsuka T; Masubuchi M; Kawasaki K; Ebiike H; Shiratori Y; Fukami TA; Kondoh O; Tsukaguchi T; Ishii N; Aoki Y; Shimma N; Sakaitani M
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1753-7. PubMed ID: 19217288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors.
    Jones P; Bottomley MJ; Carfí A; Cecchetti O; Ferrigno F; Lo Surdo P; Ontoria JM; Rowley M; Scarpelli R; Schultz-Fademrecht C; Steinkühler C
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3456-61. PubMed ID: 18440229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-thiol farnesyltransferase inhibitors: N-(4-tolylacetylamino-3-benzoylphenyl)-3-arylfurylacrylic acid amides.
    Mitsch A; Wissner P; Silber K; Haebel P; Sattler I; Klebe G; Schlitzer M
    Bioorg Med Chem; 2004 Sep; 12(17):4585-600. PubMed ID: 15358286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretical studies on farnesyl transferase: evidence for thioether product coordination to the active-site zinc sphere.
    Sousa SF; Fernandes PA; Ramos MJ
    J Comput Chem; 2007 May; 28(7):1160-8. PubMed ID: 17342704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced FTase activity achieved via piperazine interaction with catalytic zinc.
    Njoroge FG; Vibulbhan B; Pinto P; Strickland C; Bishop WR; Nomeir A; Girijavallabhan V
    Bioorg Med Chem Lett; 2006 Feb; 16(4):984-8. PubMed ID: 16298128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring structure-activity relationships of tricyclic farnesyltransferase inhibitors using ECLiPS libraries.
    Rokosz LL; Huang CY; Reader JC; Stauffer TM; Southwick EC; Li G; Chelsky D; Baldwin JJ
    Comb Chem High Throughput Screen; 2006 Aug; 9(7):545-58. PubMed ID: 16925514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-thiol farnesyltransferase inhibitors: utilization of the near aryl binding site by 5-arylacetylaminobenzophenones.
    Mitsch A; Böhm M; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2004 Apr; 337(4):213-8. PubMed ID: 15065081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
    Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
    ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.